Certara Awarded FDA Grant to Further Advance Virtual Bioequivalence Assessments of Generic Medicines Using Biosimulation
20 sept. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Certara (Nasdaq: CERT), a global leader in biosimulation, today announced the Company has been awarded a grant from the U.S. Food and Drug...
Certara Announces Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
13 sept. 2021 16h30 HE
|
Certara
PRINCETON, N.J., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it closed its public offering of 23,000,000 shares of common...
Certara Announces Pricing of Public Offering of Common Stock
08 sept. 2021 21h01 HE
|
Certara
PRINCETON, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of shares of its...
Certara Announces Proposed Public Offering of Common Stock
03 sept. 2021 06h10 HE
|
Certara
PRINCETON, N.J., Sept. 03, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a proposed underwritten public offering of 20,000,000 shares of...
Certara Reports Second Quarter 2021 Financial Results
05 août 2021 16h20 HE
|
Certara
PRINCETON, N.J., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the second quarter of fiscal year 2021. ...
Certara to Acquire Pinnacle 21, a Leader in Data Standardization Software for Pharmaceutical Clinical Data
05 août 2021 16h15 HE
|
Certara
PRINCETON, N.J., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced it has signed a definitive agreement to acquire Pinnacle 21 for...
Mubadala Invests in Global Biosimulation Leader Certara
27 juil. 2021 17h03 HE
|
Certara
PRINCETON, N.J., July 27, 2021 (GLOBE NEWSWIRE) -- Certara (NASDAQ: CERT), a global leader in biosimulation, today announced that Mubadala Investment Company (Mubadala) has made an approximately...
Certara’s Vaccine Simulator™ Accurately Predicted Optimal Timing Between Doses for COVID-19
23 juil. 2021 17h30 HE
|
Certara
PRINCETON, N.J., July 23, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced that its Vaccine Simulator accurately predicted that eight weeks was the optimal timing...
Certara Appoints Nancy Killefer and Cynthia Collins as New Independent Board Members
15 juil. 2021 16h30 HE
|
Certara
PRINCETON, N.J., July 15, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced the appointments of Nancy Killefer and Cynthia Collins to its board of directors,...
Certara to Report Second Quarter 2021 Financial Results on August 5, 2021
14 juil. 2021 16h30 HE
|
Certara
PRINCETON, N.J., July 14, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the second quarter of...